Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients With Advanced Stage Diffuse Large B-cell Lymphomas

NCT00379574 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT00379574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00379574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Bortezomib Plus CHOP Every 2 Weeks in Patients With Advanced Stage Diffuse Large B-cell Lymphomas
Lead sponsor
Asan Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2006
Completion date
January 31, 2011
Enrollment
49 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, b-cell, lymphoma, large-cell, diffuse